Marijuana Stocks & Public Companies

Photo by Vladimir Solomyani

Marijuana-focused exchange-traded fund reaches CA$1 billion in assets

Published September 10, 2018

A cannabis-focused exchange-traded fund has reached 1 billion Canadian dollars ($760 million) in assets, partly stemming from recent major investments from key players in the nation’s cannabis space ahead of the country’s recreational legalization. Horizons Marijuana Life Sciences ETF (HMMJ), which trades on the Toronto Stock Exchange, reached the milestone in assets under management in […]

Read More

MedMen inks CA$75M equity financing deal to expand US cannabis operations

Published September 7, 2018

Los Angeles-based MedMen Enterprises says it expects to raise up to 75 million Canadian dollars ($57 million) in a bought-deal equity financing plan, with the proceeds to be used to expand its U.S. retail footprint. Here’s a rundown of the deal: Toronto-based Eight Capital and Cormark Securities – as co-lead underwriters and joint bookrunners – […]

Read More

SEC sues cannabis investment fund, warns investors about MJ industry ‘scam artists’

Published September 6, 2018 | By By Omar Sacirbey

The U.S. Securities and Exchange Commission charged a marijuana-focused investment fund with bilking investors out of more than $3 million and simultaneously warned the public about “scam artists” exploiting “hot” industries such as cannabis. In a lawsuit, the SEC accuses Texas-based Greenview Investment Partners and its founder, Michael Cone, of using misleading marketing materials and bogus promises of […]

Read More

Oregon marijuana firm lands $12.5M from Canada’s Tidal Royalty to fund expansion

Published September 5, 2018

Oregon-based Diem Cannabis is poised to enter a new market after landing upwards of $12.5 million in financing from Toronto-based Tidal Royalty Corp. The capital will be used over the next three years to develop and operate a large-scale cultivation and processing facility and up to four dispensaries, all in Massachusetts, the firms announced in […]

Read More

Analyst says Cronos stock swings ‘overdone,’ calls deception allegations ‘unfounded’

Published August 31, 2018

Shares of Cronos Group were punished by investors this week after the Ontario-based licensed producer of cannabis was targeted by short-seller Andrew Left of Citron Research – but at least one analyst called the wild swing “overdone.” Citron’s report, issued Aug. 30, accused the Cronos management team of “deceiving the investing public” by not disclosing the […]

Read More

Marijuana exchange-traded fund takes in $22 million in August

Published August 31, 2018

Investors are flocking to a U.S.-listed exchange-traded fund (ETF) that tracks nearly 40 Canadian and American cannabis firms. The $436 million ETFMG Alternative Harvest ETF – which trades on the NYSE Arca under the ticker symbol MJ – has taken in around $22 million in August, putting it in a position to post its largest monthly inflow […]

Read More

Earnings highlights: Hedge fund billionaire Leon Cooperman bets on cannabis; two firms deliver solid Q2 results

Published August 30, 2018 | By Lisa Bernard-Kuhn

Share prices at cannabis firms Green Thumb Industries and Tilray are on the rise after solid second-quarter performances – and mainstream investors are taking note, with at least one hedge fund billionaire throwing his support behind the industry. The two businesses reported their first earnings as newly public companies after the markets closed Tuesday. Here’s […]

Read More

Marijuana firm Invictus to spin off vape subsidiary in move to tap US, global markets

Published August 21, 2018

Canadian cannabis producer Invictus plans to spin off wholly owned subsidiary Poda Technologies as it looks to tap into U.S. and global business opportunities. The Vancouver-based firm, which trades on the TSX Venture Exchange under the ticker symbol GENE, plans to turn Poda into a stand-alone entity valued at roughly $1.9 million, according to a […]

Read More